Publicacións nas que colabora con William J. McKenna (20)

2024

  1. Emerging Themes in Genetics of Hypertrophic Cardiomyopathy: Current Status and Clinical Application

    Canadian Journal of Cardiology

  2. Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy

    JACC: Clinical Electrophysiology, Vol. 10, Núm. 6, pp. 1178-1190

  3. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report

    International Journal of Cardiology, Vol. 395

2022

  1. Identification of an elusive spliceogenic MYBPC3 variant in an otherwise genotype-negative hypertrophic cardiomyopathy pedigree

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Preventing Sudden Death in Arrhythmogenic Cardiomyopathy: Careful Family and Genetic Evaluation Key to Appropriate Diagnosis and Management

    Canadian Journal of Cardiology

  2. Value of clinical and genetic evaluation in inherited cardiomyopathy: insights and challenges

    Journal of Cardiovascular Aging

2017

  1. Predictors of atrial fibrillation in hypertrophic cardiomyopathy

    Heart, Vol. 103, Núm. 9, pp. 672-678

2016

  1. Inverted U-Shaped Relation between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy

    Circulation: Arrhythmia and Electrophysiology, Vol. 9, Núm. 6

2015

  1. Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy

    Heart, Vol. 101, Núm. 4, pp. 294-301

  2. Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain

    Heart, Vol. 101, Núm. 13, pp. 1047-1053

  3. Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA)

    European Journal of Heart Failure, Vol. 17, Núm. 8, pp. 837-845

2014

  1. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

    European Heart Journal, Vol. 35, Núm. 30, pp. 2010-2020

2010

  1. Genetic counselling and testing in cardiomyopathies: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

    European Heart Journal

  2. Novel missense mutations in exon 15 of desmoglein-2: Role of the intracellular cadherin segment in arrhythmogenic right ventricular cardiomyopathy?

    Heart Rhythm, Vol. 7, Núm. 10, pp. 1446-1453

2008

  1. Classification of the cardiomyopathies

    Kardiologia Polska, Vol. 66, Núm. 5, pp. 533-540

  2. Classification of the cardiomyopathies: A position statement from the european society of cardiology working group on myocardial and pericardial diseases

    European Heart Journal, Vol. 29, Núm. 2, pp. 270-276

  3. What do tachycardiomyopathy belong to?: Reply

    European Heart Journal

2003

  1. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients

    Journal of the American College of Cardiology, Vol. 42, Núm. 5, pp. 873-879

2000

  1. Identificación y tratamiento de los pacientes con miocardiopatía hipertrófica y riesgo de muerte sübita

    Revista Espanola de Cardiologia, Vol. 53, Núm. 1, pp. 123-130

  2. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients

    Journal of the American College of Cardiology, Vol. 36, Núm. 7, pp. 2212-2218